Is Elevated Plasma B-Natriuretic Peptide in Amyloidosis Simply a Function of the Presence of Heart Failure?
- 22 August 2005
- journal article
- cardiomyopathy
- Published by Elsevier in The American Journal of Cardiology
- Vol. 96 (7), 982-984
- https://doi.org/10.1016/j.amjcard.2005.05.057
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- B-type natriuretic peptide in cardiovascular diseaseThe Lancet, 2003
- Longitudinal Myocardial Function Assessed by Tissue Velocity, Strain, and Strain Rate Tissue Doppler Echocardiography in Patients With AL (Primary) Cardiac AmyloidosisCirculation, 2003
- Serum N-Terminal Pro–Brain Natriuretic Peptide Is a Sensitive Marker of Myocardial Dysfunction in AL AmyloidosisCirculation, 2003
- Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosisThe American Journal of Cardiology, 2002
- Expression of Atrial and Brain Natriuretic Peptides and Their Genes in Hearts of Patients With Cardiac AmyloidosisJournal of the American College of Cardiology, 1998
- Serial Echocardiographic Observations in Patients With Primary Systemic Amyloidosis: An Introduction to the Concept of Early (Asymptomatic) Amyloid Infiltration of the HeartMayo Clinic Proceedings, 1984